Holding a blister hand, Sean Tucker, Director of American Biotechnology Science, said: This is our Covid-19 vaccine.

In order to restrain the NCOV status spread dizziness with dangerous strains, the world is trying to accelerate the Covid-19 vaccination campaign.

In an effort to overcome challenges for vaccine storage and transportation, Vaxart, based in San Francisco, hoping to solve the problem with Vaccine Covid-19 tablets, can be used on the whole world.

You can send vaccines by mail or unmanned flying device.

These types of Covid-19 vaccines are now requiring some form of cold storage to maintain efficiency, as Astrazeneca's vaccine must be kept in terms of 2-8 degrees Celsius, or vaccines of Pfizer to preserve at heat

This request poses a challenge for low and medium-income countries.

A blister with Vaccine Covid-19 potential tablet of American Biotechnology Company Vaxart.

Warm vaccines are being developed will make storage and distribution much easier, creating a revolution in pandemic response, especially in hot climates and more limited conditions, according to comments

A vaccine developed by Indian Institute of Science (IISC) and Startup of Mynvax Biotechnology Technology has created a remarkable progress in this direction.

Dr. Raghavan Varadarajan, Professor in IISC and is a co-founder of Mynvax, indicating that their vaccines will most likely be in the form of dried frozen powder, with a type of liquid support in a separate jar.

Both pulp and accompanying liquid can be stored at room temperature and transport easily.

However, the plan to produce warm vaccines is not much researched globally.

In order to meet this ignored demand, Dr. Tucker decided to pursue a plan to produce Vaccine, the strategy that Vaxart was focusing.

If everything goes smoothly, Vaxart hopes to apply for approval to use its vaccine emergency use within the next year, at the same time aiming to produce millions, even billions of vaccine doses every year at the price

Vaccine can also help solve the problem of vaccination.

However, the development of a vaccine formula is a big challenge, because it is not always effective for people like an animal test.

In addition to Vaxart, Israeli's OraMed Pharmaceutical Company is also pursuing the production of Covid-19 capsule vaccine, which is expected to start a clinical trial on the next month, soon after receiving the final approval decision

Oraamed, the company specializing in drinking oral administration for injections, in March said the Vaccine Covid-19 capsule vancine, was developed by the Cooperation Company with India Premas Biotech,

Nadav Kidron, OraMED CEO, said their capsules can also be used as an enhanced dose of vaccines, in the context of some countries who are considering the plan to increase the injection of in front of the challenge

Our drinking vaccine does not need to keep as deep as other Covid-19 vaccines.